Ultimovacs ASA

Ultimovacs ASAverified

ULTI.OL

Price:

$2.05

Market Cap:

$70.53M

Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

Industry

Biotechnology

IPO Date

2019-06-03

Stock Exchange

OSL

Ticker

ULTI.OL

The ROE as of December 2025 (TTM) for Ultimovacs ASA (ULTI.OL) is -108.91%

According to Ultimovacs ASA’s latest financial reports and current stock price. The company's current ROE is -108.91%. This represents a change of 151.56% compared to the average of -43.30% of the last 4 quarters.

Ultimovacs ASA (ULTI.OL) Historical ROE (quarterly & annually)

How has ULTI.OL ROE performed in the past?

The mean historical ROE of Ultimovacs ASA over the last ten years is -25.60%. The current -108.91% ROE has changed 325.37% with respect to the historical average. Over the past ten years (40 quarters), ULTI.OL's ROE was at its highest in in the March 2017 quarter at 0%. The ROE was at its lowest in in the December 2024 quarter at -130.30%.

Quarterly (TTM)
Annual

Average

-25.60%

Median

-26.01%

Minimum

-67.73%

Maximum

0%

Ultimovacs ASA (ULTI.OL) ROE by Quarter and Year

Discovering the peaks and valleys of Ultimovacs ASA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 107.19%

Maximum Annual ROE = 0%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -67.73%

Quarterly (TTM)
Annual
YearROEChange
20240%-100.00%
2023-67.73%107.19%
2022-32.69%16.28%
2021-28.11%17.64%
2020-23.90%90.26%
2019-12.56%-62.74%
2018-33.71%73.92%
2017-19.38%-48.93%
2016-37.95%-Infinity%

Ultimovacs ASA (ULTI.OL) Average ROE

How has ULTI.OL ROE performed in the past?

The current ROE of Ultimovacs ASA (ULTI.OL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-33.47%

5-year avg

-30.49%

10-year avg

-25.60%

Ultimovacs ASA (ULTI.OL) ROE vs. Peers

How is ULTI.OL’s ROE compared to its peers?

Ultimovacs ASA’s ROE is greater than BerGenBio ASA (-113.42%), less than Nordic Nanovector ASA (0%), greater than Targovax ASA (-206.00%), greater than Nykode Therapeutics AS (-13.25%), greater than PCI Biotech Holding ASA (-114.20%),

Build a custom stock screener for Ultimovacs ASA (ULTI.OL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ultimovacs ASA using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ultimovacs ASA (ULTI.OL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ultimovacs ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Ultimovacs ASA's ROE?

How is the ROE calculated for Ultimovacs ASA (ULTI.OL)?

What is the highest ROE for Ultimovacs ASA (ULTI.OL)?

What is the 3-year average ROE for Ultimovacs ASA (ULTI.OL)?

What is the 5-year average ROE for Ultimovacs ASA (ULTI.OL)?

How does the current ROE for Ultimovacs ASA (ULTI.OL) compare to its historical average?